BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 36112265)

  • 21. Stage 4S Neuroblastoma: A Report of Two Cases Presenting with Extremes of Biological Behavior.
    Mubarak M; Singal AK; Gawdi A
    Gulf J Oncolog; 2019 May; 1(30):81-84. PubMed ID: 31242987
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroblastoma management in Chinese children.
    Li K; Dong K; Gao J; Yao W; Xiao X; Zheng S
    J Invest Surg; 2012 Apr; 25(2):86-92. PubMed ID: 22439835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survival outcome of intermediate risk neuroblastoma at Children Cancer Hospital Egypt.
    Elzomor H; Ahmed G; Elmenawi S; Elkinaai N; Refaat A; Soliman S; Abdelwahab MA; Zaghloul MS; Fawzy M
    J Egypt Natl Canc Inst; 2018 Mar; 30(1):21-26. PubMed ID: 29428371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neonatal neuroblastoma needs the aggressive treatment?
    Nam SH; Kim DY; Kim SC; Seo JJ
    World J Surg; 2012 Sep; 36(9):2102-7. PubMed ID: 22547019
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuroblastoma in adolescents: the Italian experience.
    Conte M; Parodi S; De Bernardi B; Milanaccio C; Mazzocco K; Angelini P; Viscardi E; Di Cataldo A; Luksch R; Haupt R
    Cancer; 2006 Mar; 106(6):1409-17. PubMed ID: 16475209
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stage 4S Neuroblastoma: What Are the Outcomes? A Systematic Review of Published Studies.
    Raitio A; Rice MJ; Mullassery D; Losty PD
    Eur J Pediatr Surg; 2021 Oct; 31(5):385-389. PubMed ID: 32932540
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [4S neuroblastoma with bilateral adrenal tumors].
    Kerdudo C; Corradini N; Michon J; Leverger G
    Arch Pediatr; 2004 Dec; 11(12):1450-6. PubMed ID: 15596333
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A sequential treatment algorithm for infants with stage 4s neuroblastoma and massive hepatomegaly.
    Weintraub M; Waldman E; Koplewitz B; Bloom AI; Gross E; Freeman AI; Revel-Vilk S
    Pediatr Blood Cancer; 2012 Jul; 59(1):182-4. PubMed ID: 22605456
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Favorable biology and outcome of stage IV-S neuroblastoma with supportive care or minimal therapy: a Children's Cancer Group study.
    Nickerson HJ; Matthay KK; Seeger RC; Brodeur GM; Shimada H; Perez C; Atkinson JB; Selch M; Gerbing RB; Stram DO; Lukens J
    J Clin Oncol; 2000 Feb; 18(3):477-86. PubMed ID: 10653863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinico-pathologic characteristics and treatment outcomes in children with neuroblastoma at the Kenyatta National Hospital, Nairobi.
    Kitonyi GW; Macharia WM; Mwanda OW; Pamnani R
    East Afr Med J; 2009 Dec; 86(12 Suppl):S39-46. PubMed ID: 21591508
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liver involvement in neuroblastoma: the Memorial Sloan-Kettering Experience supports treatment reduction in young patients.
    Kushner BH; Kramer K; LaQuaglia MP; Modak S; Cheung NK
    Pediatr Blood Cancer; 2006 Mar; 46(3):278-84. PubMed ID: 16124002
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic and prognostic markers in infants with disseminated neuroblastoma: a retrospective analysis from the Italian Cooperative Group for Neuroblastoma.
    Di Cataldo A; Dau D; Conte M; Parodi S; De Bernardi B; Giuliano M; Pession A; Viscardi E; Luksch R; Castellano A; Bertuna G; Haupt R;
    Med Sci Monit; 2009 Jan; 15(1):MT11-8. PubMed ID: 19114976
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Defining Risk Factors for Chemotherapeutic Intervention in Infants With Stage 4S Neuroblastoma: A Report From Children's Oncology Group Study ANBL0531.
    Twist CJ; Naranjo A; Schmidt ML; Tenney SC; Cohn SL; Meany HJ; Mattei P; Adkins ES; Shimada H; London WB; Park JR; Matthay KK; Maris JM
    J Clin Oncol; 2019 Jan; 37(2):115-124. PubMed ID: 30444686
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comprehensive protocol for diagnosis and treatment of childhood neuroblastoma--results of 45 cases].
    Tang JY; Pan C; Chen J; Xu M; Chen J; Xue HL; Gu LJ; Dong R; Ye H; Zhou M; Wang YP
    Zhonghua Er Ke Za Zhi; 2006 Oct; 44(10):770-3. PubMed ID: 17229383
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [N-myc gene copies in children with neuroblastoma and its clinical significance].
    Ma XL; Gong LP; Zhou CJ; Zhang DW; Jin M; Wang HM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Dec; 20(6):1447-51. PubMed ID: 23257451
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neonatal neoplasms.
    Halperin EC
    Int J Radiat Oncol Biol Phys; 2000 Apr; 47(1):171-8. PubMed ID: 10758320
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical characteristics and prognostic analysis of 458 children with high-risk neuroblastoma in a single center].
    Su Y; Ma XL; Wang HM; Qin H; Qin MQ; Zhang FQ; Jin M; Zhang DW; Chen CH; Zeng Q; He LJ; Ni X
    Zhonghua Er Ke Za Zhi; 2020 Oct; 58(10):796-801. PubMed ID: 32987457
    [No Abstract]   [Full Text] [Related]  

  • 38. The Clinical Management and Outcomes of Pelvic Neuroblastic Tumors.
    Zobel M; Zamora A; Sura A; Wang L; Stein J; Marachelian A; Kim ES
    J Surg Res; 2020 May; 249():8-12. PubMed ID: 31918331
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Locoregional control in infants with neuroblastoma: role of radiation therapy and late toxicity.
    Paulino AC; Mayr NA; Simon JH; Buatti JM
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):1025-31. PubMed ID: 11958898
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MYCN oncogene amplification in neuroblastoma is associated with worse prognosis, except in stage 4s: the Italian experience with 295 children.
    Tonini GP; Boni L; Pession A; Rogers D; Iolascon A; Basso G; Cordero di Montezemolo L; Casale F; Pession A; Perri P; Mazzocco K; Scaruffi P; Lo Cunsolo C; Marchese N; Milanaccio C; Conte M; Bruzzi P; De Bernardi B
    J Clin Oncol; 1997 Jan; 15(1):85-93. PubMed ID: 8996128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.